Iluvien provides a continuous low-dose of steroids to treat diabetic macular edema. The treatment received FDA approval in 2014.
More articles on ASC issues:
10 best states for retirement
How to turn ASC staffing from a cost-center into a value center – 8 key steps
Healthcare services M&A: 10 key trends
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
